| scholarly article | Q13442814 |
| P2093 | author name string | Fang Li | |
| Elaine F Reed | |||
| Arend Mulder | |||
| Xiaohai Zhang | |||
| Yi-Ping Jin | |||
| P2860 | cites work | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 |
| mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery | Q24302549 | ||
| Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action | Q24302566 | ||
| Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive | Q24306328 | ||
| Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions | Q24651203 | ||
| Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. | Q24673519 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells | Q28203628 | ||
| The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif | Q28211968 | ||
| Focal adhesion kinase: the first ten years | Q28609173 | ||
| Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells | Q30307290 | ||
| Role of FRNK tyrosine phosphorylation in vascular smooth muscle spreading and migration. | Q30433322 | ||
| Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway | Q30436731 | ||
| The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. | Q34750527 | ||
| Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice | Q35655757 | ||
| Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets | Q35833010 | ||
| The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease | Q35846644 | ||
| FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix | Q35901036 | ||
| Mechanisms of chronic allograft dysfunction | Q36371159 | ||
| Open conformers: the hidden face of MHC-I molecules | Q36721442 | ||
| HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration | Q37426000 | ||
| Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts | Q37445163 | ||
| MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway | Q38291044 | ||
| Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis | Q40551457 | ||
| Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells | Q40560932 | ||
| FRNK inhibition of focal adhesion kinase-dependent signaling and migration in vascular smooth muscle cells. | Q40748245 | ||
| Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells | Q43688564 | ||
| Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. | Q44630596 | ||
| The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation | Q44639010 | ||
| Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability | Q45422872 | ||
| Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. | Q45881220 | ||
| Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. | Q46126109 | ||
| HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway | Q46142365 | ||
| Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. | Q46313692 | ||
| RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells | Q46386272 | ||
| HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway | Q46907583 | ||
| Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling | Q46972339 | ||
| Dual origin of intimal cells in cardiac-allograft arteriosclerosis | Q47742141 | ||
| Humoral Antibodies in Renal Allotransplantation in Man | Q47784760 | ||
| Cell tracking 2007: a proliferation of probes and applications | Q48007347 | ||
| Anti-HLA antibodies in heart transplantation. | Q51033796 | ||
| Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. | Q51770229 | ||
| Cardiac allograft vasculopathy: a review. | Q55067225 | ||
| l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty | Q64377581 | ||
| Arterial intimal thickening produced by alloantibody and xenoantibody | Q69277474 | ||
| Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells | Q69747770 | ||
| Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice | Q73987284 | ||
| Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells | Q77846900 | ||
| HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice | Q84752900 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P304 | page(s) | 1150-1159 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner | |
| P478 | volume | 72 |
| Q41849097 | Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. |
| Q37720377 | Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury |
| Q28076193 | Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation |
| Q38169496 | Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. |
| Q39366396 | Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies |
| Q36584512 | Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38226479 | Complement modulation in solid-organ transplantation. |
| Q33829159 | Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003 |
| Q26863564 | Desensitization for solid organ and hematopoietic stem cell transplantation |
| Q36544501 | Focal adhesion kinase overexpression and its impact on human osteosarcoma |
| Q47673511 | HLA Class I and Class II-Induced Intracellular Signaling and Molecular Associations in Primary Human Endothelial Cells |
| Q39149436 | HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs |
| Q37430871 | HLA class I antibody-mediated endothelial and smooth muscle cell activation |
| Q36360674 | HLA class I: an unexpected role in integrin β4 signaling in endothelial cells |
| Q27000194 | MHC class I signaling: new functional perspectives for an old molecule |
| Q27314948 | Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms |
| Q46258296 | Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection |
| Q35469913 | Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts. |
| Q92558904 | Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor-specific antibodies |
| Q40990718 | Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody |
| Q87491598 | Significance of C1q-fixing donor-specific antibodies after kidney transplantation |
| Q26862195 | The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection |
| Q38048605 | The role of complement in antibody-mediated rejection in kidney transplantation |
| Q89148849 | Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients |
| Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
Search more.